2009 annual financial data
Corcept Therapeutics 2009 Operating margin
Corcept Therapeutics 2009 operating margin with verified reported values.
Direct answer
Operating margin was -69,827.59%.
Operating income was -20,250,000 USD and net income was -20,166,000 USD.
Operating cash flow was -17,968,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,000 USD
- Operating income
- -20,250,000 USD
- Net income
- -20,166,000 USD
- Operating cash flow
- -17,968,000 USD